Image 01
Estradiol Patch, Extended Release
Product Images NDC 0781-7129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 0781-7129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 02
Image 03
Image 04
This data appears to be from a study where two groups of individuals were given either a placebo or 125 B estradiol 0.0375 mg/day for different numbered weeks, and then measurements were taken at different time points for each group. The study suggests that there was a statistically significant difference between the reduction from baseline measurements of the two groups, with the estradiol group showing more reduction.*
Image 05
The text seems to be a chart showing % change from baseline for treatment durations of 26, 52, 78, and 104 weeks. The chart includes three different treatments: Estadiol 01 gy, Estatiol 005 sy, and Estraiol 00975 mg/day, as well as a placebo. It appears to be measuring the effectiveness of the treatments over time.*
Image 06
Image 07
This text is a set of instructions for the administration of the Estradiol Transdermal System via changable patch. The patch must be changed on either Sun/Wed, Thu/Sun, Mon/Thu, Fri/Mon, Tue/Fri, or Sat/Tue, indicated by 'Q' before each day. The instruction set concludes by adding Wed/Sat as an additional patch change day option.*
Image 08
Image 09
Image 10
Image 11
Image 12
Image 13
Image 14
Image 15
Image 16
Image 17
Image 18
Image 19
Image 20
Image 21
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
